P616: Specification of frequency criteria for secondary findings genes to improve variant classification concordance

Read full text
Authors: Jennifer J. Johnston, Kristy Lee, Deborah Ritter, Steven M Harrison, Leslie G. Biesecker
Cited by: 0

Abstract

The return of secondary findings (SF) is well-established in clinical testing and is frequently employed in clinical research. The American College of Medical Genetics and Genomics (ACMG) maintains a list of monogenic disease entities (MDEs, defined as a gene-phenotype pair) for SF variant return, which is annually reviewed and updated. In 2015 the ACMG and the Association for Molecular Pathology (AMP) published criteria for classifying sequence variant pathogenicity. The Clinical Genome Resource (ClinGen), in support of maintaining and streamlining the use of ACMG SF, is providing SF-specific guidance.

Fields of Study & Subjects

Genomics and Rare Diseases BRCA gene mutations in cancer Prenatal Screening and Diagnostics

Publication details

Journal / source
Genetics in Medicine Open
Volume
4
Pages
104106–104106
Publication date
1 January 2026
Language
EN